Patents by Inventor Adria Carbo Barrios

Adria Carbo Barrios has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LANTHIONINE SYNTHETASE C-LIKE 2-BASED THERAPEUTICS
    Publication number: 20230142910
    Abstract: Provided are compounds that target the lanthionine synthetase C-like protein 2 pathway. The compounds can be used to treat a number of conditions, including infectious disease, autoimmune disease, diabetes, and a chronic inflammatory disease.
    Type: Application
    Filed: December 20, 2022
    Publication date: May 11, 2023
    Applicant: Landos Biopharma, Inc.
    Inventors: Josep Bassaganya-Riera, Adria Carbo Barrios, Richard Gandour, Julian D. Cooper, Raquel Hontecillas
  • Lanthionine synthetase C-like 2-based therapeutics
    Patent number: 11571419
    Abstract: Provided are compounds that target the lanthionine synthetase C-like protein 2 pathway. The compounds can be used to treat a number of conditions, including infectious disease, autoimmune disease, diabetes, and a chronic inflammatory disease.
    Type: Grant
    Filed: October 20, 2020
    Date of Patent: February 7, 2023
    Assignee: Landos Biopharma, Inc.
    Inventors: Josep Bassaganya-Riera, Adria Carbo Barrios, Richard Gandour, Julian D. Cooper, Raquel Hontecillas
  • LANTHIONINE SYNTHETASE C-LIKE 2-BASED THERAPEUTICS
    Publication number: 20210046070
    Abstract: Provided are compounds that target the lanthionine synthetase C-like protein 2 pathway. The compounds can be used to treat a number of conditions, including infectious disease, autoimmune disease, diabetes, and a chronic inflammatory disease.
    Type: Application
    Filed: October 20, 2020
    Publication date: February 18, 2021
    Applicant: Landos Biopharma, Inc.
    Inventors: Josep Bassaganya-Riera, Adria Carbo Barrios, Richard Gandour, Julian D. Cooper, Raquel Hontecillas
  • Lanthionine synthetase C-like 2-based therapeutics
    Patent number: 10849895
    Abstract: Provided are compounds that target the lanthionine synthetase C-like protein 2 pathway. The compounds can be used to treat a number of conditions, including infectious disease, autoimmune disease, diabetes, and a chronic inflammatory disease.
    Type: Grant
    Filed: May 4, 2020
    Date of Patent: December 1, 2020
    Assignee: LANDOS BIOPHARMA, INC.
    Inventors: Josep Bassaganya-Riera, Adria Carbo Barrios, Richard Gandour, Julian D. Cooper, Raquel Hontecillas
  • LANTHIONINE SYNTHETASE C-LIKE 2-BASED THERAPEUTICS
    Publication number: 20200261447
    Abstract: Provided are compounds that target the lanthionine synthetase C-like protein 2 pathway. The compounds can be used to treat a number of conditions, including infectious disease, autoimmune disease, diabetes, and a chronic inflammatory disease.
    Type: Application
    Filed: May 4, 2020
    Publication date: August 20, 2020
    Applicant: Landos Biopharma, Inc.
    Inventors: Josep Bassaganya-Riera, Adria Carbo Barrios, Richard Gandour, Julian D. Cooper, Raquel Hontecillas
  • Lanthionine synthetase C-like 2-based therapeutics
    Patent number: 10682349
    Abstract: Provided are compounds that target the lanthionine synthetase C-like protein 2 pathway. The compounds can be used to treat a number of conditions, including infectious disease, autoimmune disease, diabetes, and a chronic inflammatory disease.
    Type: Grant
    Filed: October 15, 2019
    Date of Patent: June 16, 2020
    Assignee: LANDOS BIOPHARMA, INC.
    Inventors: Josep Bassaganya-Riera, Adria Carbo Barrios, Richard Gandour, Julian D. Cooper, Raquel Hontecillas
  • LANTHIONINE SYNTHETASE C-LIKE 2-BASED THERAPEUTICS
    Publication number: 20200046694
    Abstract: Provided are compounds that target the lanthionine synthetase C-like protein 2 pathway. The compounds can be used to treat a number of conditions, including infectious disease, autoimmune disease, diabetes, and a chronic inflammatory disease.
    Type: Application
    Filed: October 15, 2019
    Publication date: February 13, 2020
    Applicant: Landos Biopharma, Inc.
    Inventors: Josep Bassaganya-Riera, Adria Carbo Barrios, Richard Gandour, Julian D. Cooper, Raquel Hontecillas
  • Lanthionine synthetase C-like 2-based therapeutics
    Patent number: 10493072
    Abstract: Provided are compounds that target the lanthionine synthetase C-like protein 2 pathway. The compounds can be used to treat a number of conditions, including infectious disease, autoimmune disease, diabetes, and a chronic inflammatory disease.
    Type: Grant
    Filed: December 20, 2018
    Date of Patent: December 3, 2019
    Assignee: LANDOS BIOPHARMA, INC.
    Inventors: Josep Bassaganya-Riera, Adria Carbo Barrios, Richard Gandour, Julian D. Cooper, Raquel Hontecillas
  • LANTHIONINE SYNTHETASE C-LIKE 2-BASED THERAPEUTICS
    Publication number: 20190125744
    Abstract: Provided are compounds that target the lanthionine synthetase C-like protein 2 pathway. The compounds can be used to treat a number of conditions, including infectious disease, autoimmune disease, diabetes, and a chronic inflammatory disease.
    Type: Application
    Filed: December 20, 2018
    Publication date: May 2, 2019
    Applicant: Landos Biopharma, Inc.
    Inventors: Josep Bassaganya-Riera, Adria Carbo Barrios, Richard Gandour, Julian D. Cooper, Raquel Hontecillas
  • Lanthionine synthetase C-like 2-based therapeutics
    Patent number: 10201538
    Abstract: Provided are compounds that target the lanthionine synthetase C-like protein 2 pathway. The compounds can be used to treat a number of conditions, including infectious disease, autoimmune disease, diabetes, and a chronic inflammatory disease.
    Type: Grant
    Filed: June 13, 2018
    Date of Patent: February 12, 2019
    Assignee: LANDOS BIOPHARMA, INC.
    Inventors: Josep Bassaganya-Riera, Adria Carbo Barrios, Richard Gandour, Julian D. Cooper, Raquel Hontecillas
  • LANTHIONINE SYNTHETASE C-LIKE 2-BASED THERAPEUTICS
    Publication number: 20180289703
    Abstract: Provided are compounds that target the lanthionine synthetase C-like protein 2 pathway. The compounds can be used to treat a number of conditions, including infectious disease, autoimmune disease, diabetes, and a chronic inflammatory disease.
    Type: Application
    Filed: June 13, 2018
    Publication date: October 11, 2018
    Applicant: LANDOS BIOPHARMA, INC.
    Inventors: JOSEP BASSAGANYA-RIERA, ADRIA CARBO BARRIOS, RICHARD GANDOUR, JULIAN D. COOPER, RAQUEL HONTECILLAS
  • Lanthionine synthetase C-like 2-based therapeutics
    Patent number: 10028950
    Abstract: Provided are compounds that target the lanthionine synthetase C-like protein 2 pathway. The compounds can be used to treat a number of conditions, including infectious disease, autoimmune disease, diabetes, and a chronic inflammatory disease.
    Type: Grant
    Filed: October 27, 2017
    Date of Patent: July 24, 2018
    Assignee: LANDOS BIOPHARMA, INC.
    Inventors: Josep Bassaganya-Riera, Adria Carbo Barrios, Richard Gandour, Julian D. Cooper, Raquel Hontecillas
  • LANTHIONINE SYNTHETASE C-LIKE 2-BASED THERAPEUTICS
    Publication number: 20180055841
    Abstract: Provided are compounds that target the lanthionine synthetase C-like protein 2 pathway. The compounds can be used to treat a number of conditions, including infectious disease, autoimmune disease, diabetes, and a chronic inflammatory disease.
    Type: Application
    Filed: October 27, 2017
    Publication date: March 1, 2018
    Applicant: Landos Biopharma, Inc.
    Inventors: Josep Bassaganya-Riera, Adria Carbo Barrios, Richard Gandour, Julian D. Cooper, Raquel Hontecillas
  • Lanthionine synthetase C-like 2-based therapeutics
    Patent number: 9839635
    Abstract: Provided are compounds that target the lanthionine synthetase C-like protein 2 pathway. The compounds can be used to treat a number of conditions, including infectious disease, autoimmune disease, diabetes, and a chronic inflammatory disease.
    Type: Grant
    Filed: December 9, 2016
    Date of Patent: December 12, 2017
    Assignee: LANDOS BIOPHARMA, INC.
    Inventors: Josep Bassaganya-Riera, Adria Carbo Barrios, Richard Gandour, Julian D. Cooper, Raquel Hontecillas
  • LANTHIONINE SYNTHETASE C-LIKE 2-BASED THERAPEUTICS
    Publication number: 20170119762
    Abstract: Provided are compounds that target the lanthionine synthetase C-like protein 2 pathway. The compounds can be used to treat a number of conditions, including infectious disease, autoimmune disease, diabetes, and a chronic inflammatory disease.
    Type: Application
    Filed: December 9, 2016
    Publication date: May 4, 2017
    Applicant: Biotherapeutics, Inc.
    Inventors: Josep Bassaganya-Riera, Adria Carbo Barrios, Richard Gandour, Julian D. Cooper, Raquel Hontecillas
  • Lanthionine synthetase C-like 2-based therapeutics
    Patent number: 9556146
    Abstract: Provided are compounds that target the lanthionine synthetase C-like protein 2 pathway. The compounds can be used to treat a number of conditions, including infectious disease, autoimmune disease, diabetes, and a chronic inflammatory disease.
    Type: Grant
    Filed: March 19, 2015
    Date of Patent: January 31, 2017
    Assignee: Biotherapeutics, Inc.
    Inventors: Josep Bassaganya-Riera, Adria Carbo Barrios, Richard Gandour, Julian D. Cooper, Raquel Hontecillas
  • LANTHIONINE SYNTHETASE C-LIKE 2-BASED THERAPEUTICS
    Publication number: 20160115153
    Abstract: Provided are compounds that target the lanthionine synthetase C-like protein 2 pathway. The compounds can be used to treat a number of conditions, including infectious disease, autoimmune disease, diabetes, and a chronic inflammatory disease.
    Type: Application
    Filed: March 19, 2015
    Publication date: April 28, 2016
    Applicant: Biotherapeutics, Inc.
    Inventors: Josep Bassaganya-Riera, Adria Carbo Barrios, Richard Gandour, Julian D. Cooper, Raquel Hontecillas